Ask us about our cell and gene therapy products, including both research and clinical use Discovery Leukopaks.

Discovery Life Sciences are the Biospecimen & Biomarker Specialists™. We have the world’s largest biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs in oncology, immuno-oncology, immunology, inflammation, infectious diseases, and beyond.

Our biobanks include more than 10 million biospecimens and we have hundreds of clinical sites (Discovery Partners®) that allow researchers to build bespoke study cohorts and seamlessly interrogate them using our CLIA certified, GLP-compliant service laboratories, including our world-renowned genomic sequencing and bioinformatics laboratory, HudsonAlpha Discovery, our expert IHC service laboratory that built the pembrolizumab companion diagnostic prototype, and our cell biology laboratory providing extensive cell culture and flow cytometry services with GMP-compliant leukapheresis products for cell therapy development and manufacturing.

We are committed to quality and integrity with ISO 13485, GMP compliant and CLIA-certified labs, stringent IRB and Ethics Committee compliance, and all required approvals and certifications. Navigating US and international personal data protection, drug development and diagnostic development regulations is one of our core competencies.